Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Moodys
Mallinckrodt
Harvard Business School
Colorcon

Last Updated: August 19, 2022

Investigational Drug Information for ENMD-1198


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug ENMD-1198?

ENMD-1198 is an investigational drug.

There have been 8 clinical trials for ENMD-1198. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2010.

The most common disease conditions in clinical trials are Carcinoma, Neoplasms, and Breast Neoplasms. The leading clinical trial sponsors are CASI Pharmaceuticals, Inc., University Health Network, Toronto, and Indiana University Melvin and Bren Simon Cancer Center.

Recent Clinical Trials for ENMD-1198
TitleSponsorPhase
A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar CarcinomaCASI Pharmaceuticals, Inc.Phase 2
A Study of ENMD-2076 in Ovarian Clear Cell CancersUniversity Health Network, TorontoPhase 2
Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue SarcomaUniversity Health Network, TorontoPhase 2

See all ENMD-1198 clinical trials

Clinical Trial Summary for ENMD-1198

Top disease conditions for ENMD-1198
Top clinical trial sponsors for ENMD-1198

See all ENMD-1198 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Moodys
Mallinckrodt
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.